Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.
about
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyConsiderations and challenges in defining optimal iron utilization in hemodialysisSafety of intravenous iron in hemodialysis patients.Atherogenesis and iron: from epidemiology to cellular level.Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.Intravenous iron exposure and mortality in patients on hemodialysisReassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study.Comparison of short-term efficacy of iron sucrose with those of ferric chloride in hemodialysis patients: An open-label study.Anaemia management in patients with chronic kidney disease: Taiwan practice guidelines.The Labile Side of Iron Supplementation in CKDImpact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution.Diagnosing and preventing iron overload.Successful creation of an anemia management algorithm for hemodialysis patients.Intravenous iron exposure and outcomes in patients on hemodialysis.Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis.Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.The safety of available treatment options for iron-deficiency anemia.Safety of Intravenous Iron in Dialysis: A Systematic Review and Meta-Analysis.Optimal Serum Ferritin Levels for Iron Deficiency Anemia during Oral Iron Therapy (OIT) in Japanese Hemodialysis Patients with Minor Inflammation and Benefit of Intravenous Iron Therapy for OIT-Nonresponders.Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients.Iron parameters in patients with end-stage renal disease receiving lanthanum carbonate or other non-iron-based phosphate binders: Results from a phase 3, randomized open-label study
P2860
Q26752664-D184047E-4D84-4FB8-9443-9A632B40B141Q28088564-8C81A322-D0DC-4E36-AD00-557D6CD9C3B8Q30234981-F2D84820-ECEE-4526-8366-0F6BFF9212F2Q33595279-A25C1056-B26E-42E3-BF5D-5261608A6FE3Q34427619-74B5C295-E669-4C48-93E5-7308A5207AC3Q34455198-752424B9-DD23-4DCD-A59F-220D3DCD130AQ35693595-36C58B8E-9A3C-485C-8550-A6029679D737Q37593694-D12EDF61-CA3C-4D04-9B97-F5CFC0A6D944Q38243244-866C6E9A-DDF2-4BD3-83A9-1763CB7BD62FQ38496987-ADDD2D5A-2786-4600-ABEA-648675513459Q38884441-3C9E830A-BFA2-48B7-B8BC-B42D3448B98FQ39192941-65C8FC16-7A14-4312-AA67-4A45772FDFF8Q41621194-A683930B-D0BA-4FEF-B510-B3BFB4AFF571Q42975965-519395EF-B38C-44FF-A8A9-7C0A30D89FB0Q47835950-FC2A62A5-102E-4C5D-B293-8A328EF57BD9Q48086832-FD12CEE0-6133-48B0-B102-E50896B4AF90Q48140646-A0E56BE3-F57D-45A4-9B3B-DFAD080C41CCQ48548255-897650C5-3F1F-4ADE-BB71-60FA2F629A59Q49791535-BF9390AD-1393-47C3-96D2-9D5DC1CA9597Q52381914-A2F8E2CC-D7DE-4751-AA7D-4B7DEBA09C6EQ55184664-42D46B65-7273-4F85-8271-A41C21F28555Q55347421-5DBC82DF-3F97-468F-9D7B-E9487B576309Q57213827-56626C00-7667-409C-BF4E-5A38B723B5E8
P2860
Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Intravenous ferric chloride he ...... k among hemodialysis patients.
@ast
Intravenous ferric chloride he ...... k among hemodialysis patients.
@en
Intravenous ferric chloride he ...... k among hemodialysis patients.
@nl
type
label
Intravenous ferric chloride he ...... k among hemodialysis patients.
@ast
Intravenous ferric chloride he ...... k among hemodialysis patients.
@en
Intravenous ferric chloride he ...... k among hemodialysis patients.
@nl
prefLabel
Intravenous ferric chloride he ...... k among hemodialysis patients.
@ast
Intravenous ferric chloride he ...... k among hemodialysis patients.
@en
Intravenous ferric chloride he ...... k among hemodialysis patients.
@nl
P2093
P2860
P1433
P1476
Intravenous ferric chloride he ...... k among hemodialysis patients.
@en
P2093
Chih-Pei Lin
Ching-Fang Tang
Der-Cherng Tarng
Ko-Lin Kuo
Szu-Chun Hung
Yao-Ping Lin
P2860
P304
P356
10.1371/JOURNAL.PONE.0050295
P407
P577
2012-12-05T00:00:00Z